Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -9.94%6.45B | -9.90%1.61B | -14.11%1.56B | -0.53%7.17B | -9.37%1.84B | -11.50%1.73B | 13.81%1.78B | 9.74%1.81B | 16.48%7.2B | 21.08%2.03B |
| Cost of revenue | -8.54%5.15B | -10.25%1.26B | -11.63%1.24B | 1.91%5.63B | -6.13%1.46B | -12.10%1.36B | 20.82%1.41B | 11.64%1.4B | 15.39%5.52B | 21.35%1.56B |
| Gross profit | -15.06%1.31B | -8.61%341.72M | -22.43%322.7M | -8.55%1.54B | -20.19%373.15M | -9.27%373.52M | -6.60%373.93M | 3.81%416.02M | 20.22%1.68B | 20.19%467.54M |
| Operating expense | 0.16%1.44B | 5.87%387.54M | -4.03%328.16M | 4.94%1.44B | 0.51%368.97M | 5.13%359.37M | 9.36%366.06M | 5.21%341.96M | 6.40%1.37B | 3.07%367.09M |
| Operating profit | -233.05%-133.4M | -682.47%-45.82M | -107.37%-5.46M | -67.83%100.26M | -95.84%4.18M | -79.74%14.15M | -88.01%7.87M | -2.17%74.06M | 179.97%311.62M | 205.86%100.45M |
| Net non-operating interest income (expenses) | -54.43%-49.87M | -44.64%-10.46M | -52.90%-10.17M | -30.88%-32.29M | -73.88%-10.5M | -22.02%-7.9M | -15.14%-7.23M | -13.27%-6.65M | -5.20%-24.67M | -8.53%-6.04M |
| Non-operating interest income | 9.29%2.1M | 90.44%817K | 4.34%361K | 62.05%1.92M | 211.93%758K | 22.68%384K | 32.00%429K | 14.57%346K | -12.76%1.18M | -35.71%243K |
| Non-operating interest expense | 51.90%51.96M | 47.20%11.28M | 50.49%10.53M | 32.31%34.21M | 79.22%11.26M | 22.05%8.29M | 15.97%7.66M | 13.33%7M | 4.22%25.85M | 5.72%6.28M |
| Net investment income | 2.24%36.75M | -24.62%21.05M | 61.50%12.6M | 191.04%35.94M | 65.56%-12.85M | 151.53%13.08M | 42.80%27.92M | 112.53%7.8M | -289.69%-39.48M | -389.00%-37.33M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -101.18%-323K | 0 | -709K | 240.47%27.47M | 795.86%29.42M | -556.44%-1.95M | 0 | 0 | -19.56M | 3.28M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -63.41%-58.27M | -609.02%-22.1M | 0 | 21.03%-35.66M | -19,876.54%-32.36M | -307.14%-342K | 93.06%-3.12M | 163K | -3,768.98%-45.15M | 84.06%-162K |
| Less:Other special charges | -111.26%-333K | ---- | ---- | -93.45%2.96M | -308.64%-338K | 307.14%342K | --3.12M | ---163K | 3,768.98%45.15M | -84.06%162K |
| Less:Write off | 79.20%58.6M | ---- | ---- | --32.7M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 20.04%42.15M | 42.72%12.7M | 3.92%8.91M | -11.59%35.11M | -7.36%10.05M | -44.36%7.59M | 25.59%8.9M | 5.38%8.57M | 46.87%39.72M | -31.24%10.85M |
| Income before tax | -224.55%-162.96M | -230.01%-44.64M | -93.83%5.18M | -41.19%130.84M | -116.98%-12.06M | -52.63%24.62M | 92.69%34.33M | 2.83%83.95M | 114.76%222.48M | 106.53%71.05M |
| Income tax | 22.16%78.79M | -97.27%312K | -79.40%6.36M | -16.38%64.5M | -63.20%3.44M | 84.71%18.74M | -33.78%11.44M | -23.52%30.89M | 213.57%77.13M | 180.06%9.33M |
| Net income | -464.40%-241.75M | -296.32%-44.95M | -102.23%-1.18M | -54.35%66.34M | -125.11%-15.5M | -85.94%5.88M | 4,085.92%22.9M | 28.62%53.07M | 83.99%145.35M | 34.00%61.72M |
| Net income continuous operations | -464.39%-241.75M | -296.32%-44.95M | -102.23%-1.19M | -54.35%66.34M | -125.11%-15.5M | -85.94%5.88M | 4,093.41%22.9M | 28.62%53.07M | 83.99%145.35M | 33.99%61.72M |
| Noncontrolling interests | -502.21%-60.34M | -217.52%-15.8M | -167.40%-8.02M | 23.60%15M | 179.54%20.4M | -162.35%-12.31M | -547.07%-4.98M | -36.77%11.89M | -58.33%12.14M | -291.38%-25.65M |
| Net income attributable to the company | -453.35%-181.41M | -204.58%-29.15M | -83.41%6.83M | -61.46%51.34M | -141.09%-35.9M | -17.58%18.19M | 2,018.01%27.87M | 83.38%41.17M | 167.13%133.21M | 167.52%87.36M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -453.35%-181.41M | -204.58%-29.15M | -83.41%6.83M | -61.46%51.34M | -141.09%-35.9M | -17.58%18.19M | 2,018.01%27.87M | 83.38%41.17M | 167.13%133.21M | 167.52%87.36M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -453.33%-146.63 | -204.62%-23.56 | -83.41%5.52 | -61.45%41.5 | -141.09%-29.01 | -17.54%14.71 | 2,024.53%22.52 | 83.36%33.28 | 167.12%107.65 | 167.53%70.6 |
| Diluted earnings per share | -453.33%-146.63 | -204.62%-23.5604 | -83.41%5.52 | -61.45%41.5 | -141.10%-29.017 | -17.58%14.7037 | 2,024.53%22.52 | 83.36%33.28 | 167.12%107.65 | 167.53%70.6 |
| Dividend per share | 0.00%30 | 0.00%15 | 0 | -33.33%30 | -50.00%15 | 0 | 0.00%15 | 0 | 50.00%45 | 0.00%30 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |